Company Analysis

Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · Pharmaceutical Preparations · Tel Aviv · filing with the SEC since 1996
Grade5.8
◀ Past 5.9● Present 6.3▶ Future 4.9

Income statement, as filed

In millions of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedFeb 3, 2026Feb 5, 2025Feb 12, 2024Feb 10, 2023Feb 9, 2022Feb 10, 2021Feb 21, 2020Feb 19, 2019Feb 12, 2018Feb 15, 2017
Revenue17,25816,54415,84614,92515,87816,65916,88718,271r21,853r21,903
Cost of revenue8,3208,4818,2007,9528,2848,9339,3519,975r11,237r10,250
Gross profit8,9388,0647,6456,9737,5947,7267,5378,29610,61511,653
Research and development1,0139989538389679971,0101,2131,7782,077
Sales and marketing2,6862,5412,3362,2652,4292,4982,6142,9163,3953,583
General and administrative1,2871,1611,1621,1801,0991,1731,1921,2981,4511,390
Operating income2,157-303433-2,197r1,716-3,572-443-1,637-17,4842,154
Interest expense9161,0021,029930891901r822r920875546
Interest and investment income·····10441398451
Share of profit of equity-method investments1512219138-13-71-38
Total non-operating income (expense)-934-981-1,057-966-1,058-834-822-959-895-1,330
Income before income taxes1,223-1,284-624-3,163r658-4,406-1,265-2,596-18,379824
Income tax expense-180676-7-643r211-168-278-195-1,933521
Net income including non-controlling interests1,418-1,959-615-2,499r456-4,099-1,000-2,472-16,449311
Net income to non-controlling interests7-320-56-5339-109-2-322-184-18
Net income1,410-1,639-559-2,446r417-3,990-999-2,150-16,265329
Preferred dividends·······249260261
Net income to common shareholders·····-3,990-999-2,399-16,52568
Earnings per share, basic1.23-1.45-0.50-2.20r0.38-3.64-0.91-2.35-16.260.07
Earnings per share, diluted1.21-1.45-0.50-2.20r0.38-3.64-0.91-2.35-16.260.07
Earnings per share, basic and diluted····0.383.640.912.35··
Weighted average shares, basic1,145,000,0001,131,000,0001,119,000,0001,110,000,0001,102,000,0001,095,000,0001,091,000,0001,021,000,000r1,016,000,000r955
Weighted average shares, diluted1,163,000,0001,131,000,0001,119,000,0001,110,000,0001,107,000,0001,095,000,0001,091,000,0001,021,000,000r1,016,000,000r961
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeNonoperating
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Preferred dividends paid to preferred holders before common shareholdersus-gaap:PreferredStockDividendsIncomeStatementImpact
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton TEVA · research, not advice